Buscar
Itens para a visualização no momento 1-5 of 5
Coagulation dysfunction in COVID-19: the interplay between inflammation, viral infection and the coagulation system
COVID-19 is a new pandemic, caused by Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-Cov2)
infection and characterized by a broad spectrum of clinical manifestations.
Inflammation and the innate immune system have ...
The possible mechanisms of action of 4-aminoquinolines (chloroquine/ hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
The anti-malarial drugs chloroquine (CQ) and primarily the less toxic hydroxychloroquine (HCQ) are currently
used to treat autoimmune diseases for their immunomodulatory and anti-thrombotic properties. They have also
been ...
Thromboinflammation in COVID-19 acute lung injury
Since the initial description in 2019, the novel coronavirus SARS-Cov-2 infection (COVID-19) pandemic
has swept the globe. The most severe form of the disease presents with fever and shortness of breath,
which rapidly ...
COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?
A Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) has become a pandemic disease named
Coronavirus Disease-19 (COVID-19) of epochal dimension. The clinical spectrum of COVID-19 is wide, ranging
from asymptomatic ...
Therapeutic promises of ginkgolide A: A literature-based review
Ginkgolide A is a highly active platelet activating factor antagonist cage molecule which was isolated from the
leaves of the Ginkgo biloba L. It is known for its inflammatory and immunological potentials. This review ...